Scientific Meeting

科学会议

• 批准号: 7251414
• 负责人: CATHERINE M VERFAILLIE
• 金额: $ 0.5万
• 依托单位: INTERNATIONAL SOCIETY/EXPER HEMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-26 至 2007-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7251414
• 关键词: biological products; hematology; meeting /conference /symposium; stem cell transplantation; travel

DESCRIPTION (provided by applicant): Use of stem cells as a therapeutic modality has great potential beyond that currently implemented for patients with inherited or acquired hematologic disorders. However, little is known regarding the manufacturing of stem cells from an industry perspective, GMP procedures that will be required for a stem cell product, methods to infuse the cells and have them home properly to the tissue in need of repair, the impact of aging on stem cells used as a therapeutic, ways to manipulate leukemic stem cells via their environment, and the response of patients to the transplanted cells (or the graft to the host). This ISEH program will bring together experts in each of these areas to present the most recent information to the physicians, scientists, and industry personnel in attendance.

描述（由申请人提供）： 使用干细胞作为治疗方式具有超出目前实施的巨大潜力 对于患有遗传性或获得性血液系统疾病的患者。然而，从行业角度来看，人们对干细胞的制造、干细胞产品所需的 GMP 程序、注入细胞并使它们正确归巢到需要修复的组织的方法、衰老的影响知之甚少。用作治疗的干细胞、通过其环境操纵白血病干细胞的方法以及患者对移植细胞（或移植到宿主的移植物）的反应。该 ISEH 计划将汇集各个领域的专家，向出席的医生、科学家和行业人员提供最新信息。